Elliot W. Ehrich
2015
In 2015, Elliot W. Ehrich earned a total compensation of $4.4M as Executive Vice President, Research and Development and Chief Medical Officer at Alkermes, a 37% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $604,890 |
|---|---|
| Option Awards | $2,155,813 |
| Salary | $513,910 |
| Stock Awards | $1,068,450 |
| Other | $13,275 |
| Total | $4,356,338 |
Ehrich received $2.2M in option awards, accounting for 49% of the total pay in 2015.
Ehrich also received $604.9K in non-equity incentive plan, $513.9K in salary, $1.1M in stock awards and $13.3K in other compensation.
Rankings
In 2015, Elliot W. Ehrich's compensation ranked 1,939th out of 13,638 executives tracked by ExecPay. In other words, Ehrich earned more than 85.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,939 out of 13,638 | 86th |
Division Manufacturing | 694 out of 5,187 | 87th |
Major group Chemicals And Allied Products | 251 out of 1,857 | 87th |
Industry group Drugs | 196 out of 1,531 | 87th |
Industry Pharmaceutical Preparations | 159 out of 1,179 | 87th |
Source: SEC filing on April 13, 2017.
Ehrich's colleagues
We found four more compensation records of executives who worked with Elliot W. Ehrich at Alkermes in 2015.